Suppr超能文献

采用液相色谱-大气压化学电离质谱法测定体液中的吗啡及其3-和6-葡萄糖醛酸苷、可待因、可待因-葡萄糖醛酸苷和6-单乙酰吗啡。

Determination of morphine and its 3- and 6-glucuronides, codeine, codeine-glucuronide and 6-monoacetylmorphine in body fluids by liquid chromatography atmospheric pressure chemical ionization mass spectrometry.

作者信息

Bogusz M J, Maier R D, Erkens M, Driessen S

机构信息

Institute of Forensic Medicine, Aachen University of Technology, Germany.

出版信息

J Chromatogr B Biomed Sci Appl. 1997 Dec 5;703(1-2):115-27. doi: 10.1016/s0378-4347(97)00384-8.

Abstract

A selective assay of morphine-3-glucuronide (M3G), morphine-6-glucuronide (M6G), morphine, codeine, codeine-6-glucuronide (C6G) and 6-monoacetylmorphine (6-MAM) based on liquid chromatography atmospheric pressure chemical ionization mass spectrometry (LC-APCI-MS) is described. The drugs were extracted from serum, autopsy blood, urine, cerebrospinal fluid or vitreous humor using C18 solid-phase extraction cartridges and subjected to LC-APCI-MS analysis. The separation was performed on an ODS column in acetonitrile-50 mM ammonium formate buffer, pH 3.0 (5:95), using a flow-rate gradient from 0.6 to 1.1 ml/min (total analysis time was 17 min). The quantitative analysis was done using deuterated analogues of each compound. Selected-ion monitoring detection was applied: m/z 286 (for morphine, M3G-aglycone and M6G-aglycone), 289 (for morphine-d3, M3G-d3-aglycone and M6G-d3-aglycone), 300 (for codeine and C6G-aglycone), 303 (for C6G-d3-aglycone), 306 (for codeine-d6), 328 (for 6-MAM), 334 (for 6-MAM-d6), 462 (for M3G and M6G), 465 (for M3G-d3 and M6G-d3), 476 (for C6G) and 479 (for C6G-d3). The limits of quantitation were: 1 microg/l for morphine, 2 microg/l for 6-MAM, 5 microg/l for M3G, M6G and codeine and 200 microg/I for C6G. The recovery ranged from 85 to 98% for each analyte. The method appeared very selective and may be used for the routine determination of opiates in body fluids of heroin abusers and patients treated with opiates.

摘要

本文描述了一种基于液相色谱-大气压化学电离质谱法(LC-APCI-MS)对吗啡-3-葡萄糖醛酸苷(M3G)、吗啡-6-葡萄糖醛酸苷(M6G)、吗啡、可待因、可待因-6-葡萄糖醛酸苷(C6G)和6-单乙酰吗啡(6-MAM)的选择性检测方法。使用C18固相萃取柱从血清、尸检血液、尿液、脑脊液或玻璃体液中提取这些药物,然后进行LC-APCI-MS分析。分离在ODS柱上进行,流动相为乙腈-50 mM甲酸铵缓冲液(pH 3.0,5:95),流速从0.6至1.1 ml/min呈梯度变化(总分析时间为17分钟)。定量分析使用各化合物的氘代类似物进行。采用选择离子监测检测:m/z 286(针对吗啡、M3G苷元及M6G苷元)、289(针对吗啡-d3、M3G-d3苷元及M6G-d3苷元)、300(针对可待因及C6G苷元)、303(针对C6G-d3苷元)、306(针对可待因-d6)、328(针对6-MAM)、334(针对6-MAM-d6)、462(针对M3G及M6G)、465(针对M3G-d3及M6G-d3)、476(针对C6G)及479(针对C6G-d3)。定量限分别为:吗啡1 μg/l、6-MAM 2 μg/l、M3G、M6G及可待因各5 μg/l、C6G 200 μg/I。各分析物的回收率在85%至98%之间。该方法选择性很强,可用于常规测定海洛因滥用者及接受阿片类药物治疗患者体液中的阿片类物质。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验